Therapeutic Areas

Infectious Disease Clinical Development Expertise

Getting a novel infectious disease vaccine or treatment on the market today is extremely critical and complex.

Infectious diseases are a threat to global health and way of life everywhere – particularly in the midst of the current COVID-19 pandemic. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.  In addition to recent pandemic outbreaks caused by viral infections, more treatment-resistant bacterial and fungal infections are rising, with antibiotics and anti-fungals becoming less effective.

Our scientific-minded infectious disease experts can help navigate this challenging landscape, having conducted nearly  350 projects for Infectious Disease treatments and vaccines.

Experience Battling Infectious Diseases

Whether you are aiming to prevent or combat a viral, bacterial, fungal or parasitic infection, Veristat can help make the difference for your study’s success. Our teams understand the nuances and difficulties involved with treating infectious diseases, have the experience to perform vaccine trials, and are adept with rapid response to global pandemics that arise, such as the recent and somewhat ongoing  COVID-19 response.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:    

Recent Pandemic Experience

Nearly 350

Projects for infectious disease treatments and vaccines

70+ COVID-19

vaccines/therapies

60+ Influenza

vaccine programs

8 Ebola

vaccine projects for 2014 outbreak

Explore Our Recent Infectious Disease Experience

Prevention and Treatment of Bacterial & Fungal Infections
Acinetobacter Baumannii Infections Gram-Negative Infections
Acute Bacterial Skin and Skin Structure Infections (ABSSI) H. Pylori Infection
Bacterial Pneumonia Joint infection
Botulinum vaccine Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia
Candidemia Nasal Infection
Clostridium Difficile (C.Diff) Nontuberculous Mycobacterial (NTM) Lung Disease
Complicated Intra-Abdominal Infections (cIAI) Nosocomial Infection
Complicated Skin and Skin Structure Infection (CSSSI) Onychomycosis
Complicated Urinary Tract Infection including Pyelonephritis Staphylococcus Aureus
Cystic Fibrosis-Pseudomonas Surgical Site Infections
Endocarditis Vacomycin-Resistant Enterococcal Infections
Prevention and Treatment of Viruses/Viral Infection​
COVID 19 Influenza - Pandemic
Cytomegalovirus (CMV) Infection Lassa Fever
Ebola Malaria
Epstein Barr Virus (EBV) Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Hepatitis A, B & C Recurrent Respiratory Papillomatosis (RRP)
Herpes (HSV2) Respiratory Syncytial Virus
HIV / AIDS RNA Vaccine Platforms for multiple types of Infectious Diseases/Cancers
Human Papilloma Virus (HPV) Shingles - Varicella-Zoster Virus (VZV)
Influenza - H1N1 Smallpox
Influenza - H5N1 Sexually Transmitted Infections
Influenza - Seasonal Typhoid Fever
Influenza (Universal Vaccine) West Nile Virus

Learn More With These Resources

Fact Sheet

Veristat Corporate Fact Sheet

Infographic

Marketing Applications Approval Record

Webinar Presentation

Webinar Presentation: Expanding your Clinical Trial into the ...